Breaking News
March 18, 2019 - Fibromyalgia can be reliably detected in blood samples
March 18, 2019 - Legacy Pharmaceutical Packaging, LLC Issues Voluntary Nationwide Recall of Losartan Potassium Tablets, USP, 25mg, 50mg, And 100mg Due to The Detection of Trace Amounts Of N-Nitroso N-Methyl 4-Amino Butyric Acid (NMBA) Impurity Found in The Active Pharmaceutical Ingredient (API)
March 18, 2019 - Researchers identify early home and family factors that contribute to obesity
March 18, 2019 - Fate and festivity: Match Day 2019
March 18, 2019 - Study finds TAVR to be as good as open-heart surgery for patients at low surgical risk
March 18, 2019 - EU-funded project is developing new tools for diagnosing cancer
March 18, 2019 - Gluten, lactose, food dyes in pills could be causing side effects finds study
March 18, 2019 - Taking painkillers during pregnancy is not responsible for asthma risk in children, study shows
March 18, 2019 - Prediagnosis Psychiatric Care Linked to Worse Cancer Mortality
March 18, 2019 - Paris hospital halts stool study after donor deluge
March 18, 2019 - Partial oral antibiotic therapy shows efficacy and safety in patients with infectious endocarditis
March 18, 2019 - Olympus improves access to science education through BioBus collaboration
March 18, 2019 - Depression screening does not improve quality of life in heart attack patients
March 18, 2019 - Echocardiography may aid in patient selection for TMVR
March 18, 2019 - Are ‘Inactive’ Ingredients in Your Drugs Really So Harmless?
March 18, 2019 - Wearable technology can safely identify atrial fibrillation
March 18, 2019 - Scientists tackle rare retinal disease in unique research project
March 18, 2019 - Death By A Thousand Clicks
March 18, 2019 - Absorbable, antibiotic-eluting envelope can reduce rate of cardiac device infections
March 18, 2019 - Hormonal treatment associated with depression in men with prostate cancer
March 18, 2019 - Porvair Sciences launches reinforced 96-well deep round microplate
March 18, 2019 - Simplified catheter ablation could slash waiting lists for atrial fibrillation patients
March 18, 2019 - BFR therapy as part of rehabilitation following ACL surgery may slow bone loss
March 18, 2019 - A human model to test implants for cataract surgery
March 18, 2019 - New risk adjustment model could reduce financial penalty for safety net hospitals
March 18, 2019 - NHS cancer patients’ wait to start treatment worrying
March 18, 2019 - Inventiva Announces Results from Phase IIb Clinical Trial with Lanifibranor in Systemic Sclerosis
March 18, 2019 - Cologuard
March 18, 2019 - Researchers find evidence of prenatal environment tuning genomic imprinting
March 18, 2019 - Dolomite Bio launches novel Nadia product family for single-cell research
March 18, 2019 - Intellipharmaceutics Announces Resubmission of New Drug Application to the U.S. FDA for its Oxycodone ER
March 18, 2019 - Excessive gestational weight gain tied to maternal morbidity
March 18, 2019 - RCEM issues position statement on metrics to supplement four-hour standard target
March 17, 2019 - Noncontrast Brain MRI Effective for Monitoring Multiple Sclerosis
March 17, 2019 - Brain region plays key role in regulation of parenting behavior, study finds
March 17, 2019 - Natural speed limit on DNA replication sets pace for life’s first steps
March 17, 2019 - New research reveals overlooked impact of herbicide glyphosate on the environment
March 17, 2019 - Molecular patterns could help predict relapse risk in breast cancer patients
March 17, 2019 - Study confirms sensitivity of microbiological cultures for detecting cholera
March 17, 2019 - Scientists Spot Clues to Predicting Breast Cancer’s Return
March 17, 2019 - Scientists identify gene that keeps PTSD-like behavior at bay in female mice
March 17, 2019 - New method would allow doctors to detect earliest stages of cancers in the lymph nodes
March 17, 2019 - Cholesterol protein discovery raises hope for smarter drugs
March 17, 2019 - New insect medium delivers high viable cell density growth and protein yield
March 17, 2019 - Opioid crisis brings concerns about heart dangers
March 17, 2019 - Resistance Training May Prevent Type 2 Diabetes Progression
March 17, 2019 - Bioluminescence sensors make new approaches to drug discovery possible
March 17, 2019 - New FDA Rules Aim to Keep Kids From Flavored E-Cigarettes
March 17, 2019 - Vitamin B3 analogue boosts production of blood cells
March 17, 2019 - Government cuts to stop smoking services have detrimental impact on public health
March 17, 2019 - Common tool to assess potential adoptive parents lags behind societal changes
March 17, 2019 - Patients’ own cells could be the key to treating Crohn’s disease
March 17, 2019 - Diagnostic delays common in inflammatory bowel disease
March 17, 2019 - Study uncovers dramatic differences in the brains of Hispanics with dementia
March 17, 2019 - Study describes epigenetic loss that changes how cells obtain energy from cancer
March 16, 2019 - Active Bathing in Non-ICU Setting Does Not Cut Infections
March 16, 2019 - How the immune system maintains a healthy gut microbiota
March 16, 2019 - Bacteria ‘trap’ could help in the fight against antimicrobial resistance
March 16, 2019 - Hospital work environment associated with all EHR usability outcomes
March 16, 2019 - Study unravels mystery behind how the brain encodes time when forming long-term memories
March 16, 2019 - Light physical activity may lower risk of cardiovascular disease in older women
March 16, 2019 - USP15 enzyme could potentially lead to new treatments for breast, pancreatic cancer
March 16, 2019 - After Chinese Infant Gene-Editing Scandal, U.S. Health Officials Join Call for a Ban
March 16, 2019 - PACS1 syndrome – Genetics Home Reference
March 16, 2019 - Researchers discover an unexpected organization of antimicrobial molecules that amplifies immune response
March 16, 2019 - With New Study, Era of Open-Heart Surgery for Aortic Stenosis May be Ending
March 16, 2019 - Dolomite Bio introduces high throughput sNuc-Seq protocol for its Nadia Instrument
March 16, 2019 - New course prepares materials scientists for biomedical testing
March 16, 2019 - Finding clues to a functional HIV cure
March 16, 2019 - People with chronic periodontitis have higher risk for dementia
March 16, 2019 - Few heart care recommendations are based on rigorous study
March 16, 2019 - Colorectal cancer diagnosed at early age is distinct from that in older patients
March 16, 2019 - Researchers use MRI and AI techniques at birth to predict cognitive development at age 2
March 16, 2019 - Discarding information from the brain linked to more mental effort, finds study
March 16, 2019 - OTA International supplement provides current snapshot and forward look at global trauma systems
March 16, 2019 - NIH trial to track outcomes of liver transplantation from HIV+ donors to HIV+ recipients
March 16, 2019 - Apple Heart Study shows how wearable technology can help detect heart problem
March 16, 2019 - Researchers determine factors that cause stress development in the human body
March 16, 2019 - Elderly Men Undertreated for Osteoporosis
March 16, 2019 - People with chronic pain are coping with the help of Pinterest, new study reveals
The Human Microbiome – A New Potential Fingerprint in Forensic Evidence?

The Human Microbiome – A New Potential Fingerprint in Forensic Evidence?

image_pdfDownload PDFimage_print

An interview with Professor Jack Gilbert, conducted by Alina Shrourou, BSc.

What is a microbiome and why are microbiomes unique to an individual?

A microbiome is the sum total of the microbes of bacteria, fungi, and viruses that live inside your body. They are all over your skin and in your gut. Bacteria alone accounts for 2-3 lbs of your body mass.

© vrx/Shutterstock.com

What’s interesting is that when you’re born, you’re mostly sterile. You acquire microbes from your mother and the environment. Then, the way you live your life and the things you interact with shape the kind of microbes that colonize and live inside you. This results in your own unique profile, and even identical twins have different profiles.

Please outline the Burglary Microbiome Project that you discussed at Pittcon 2018.

We’ve been trying to understand if our bacterial signature can act like a fingerprint, and be used as some kind of forensic tool, like trace evidence.

We emit around 36 million bacterial cells into our immediate environment every single hour – so if a burglar in a room for 10 minutes touches objects and leaves behind some their bacteria, can we detect their personal bacterial signature by obtaining some of the bacteria present in the room?

It could then be possible to sequence the information, as we do with human DNA at a crime scene, and therefore identify that individual.

It’s an interesting idea, and at the moment it’s a very early research project that we’re working on with the National Institute of Justice.

How do you determine whether a microbial organism is associated with a particular trait?

We’ve been trying to see if the bacterial signature that lives inside us is somehow correlated with our lifestyle choices.

The signature that belongs to you is very much determined by how you’ve lived your life; whether you had pets growing up, whether you grew up in a city or a farm etc, are all factored in.

Different working environments can determine what bacteria live inside you, how they grow and how they’re distributed, so we wanted to see if that correlates. We built up a database of over 12,000 people and we’ve been correlating how similar our mock burglars microbiome signatures are to people in our database. It’s complicated, but we’re getting really close to identifying somebody’s lifestyle traits based on the microbial signature they leave behind at a crime scene.

What analytical techniques are you using to identify microbial biomarkers?

We leverage genome sequencing, especially the Illumina platforms – DNA extraction, and PCR amplification, much the same way as we would with human DNA sequences. We identify a particular gene present in all bacteria which we then sequence and use to determine which bacterial organisms are present in different subjects and what makes an individual unique.

We then produce a probability estimate that your bacteria would be found in a certain environment. Using advanced statistical techniques, we try and identify whether your bacteria’s sequencing data can place you at that crime scene.

Please outline any specific biomarkers that you have already identified in this project.

The way in which we analyze the microbiota is by looking for unique strains of organisms. We all have one particular species of E. coli living inside our gut, and we all have Staphylococcus epidermidis living in our skin, but each individual has a strain with a genotype and genome unique to them. It evolves with you and mutates over time, and we call those mutations biomarkers.

We’re using that information to try and identify whether we can pull out particular genotypic mutations, or biomarkers, which are unique to an individual.

If an individual’s lifestyle can change throughout their lifetime, does this mean that their microbiome can too? If so, are microbiome signatures always an accurate identification tool?

We are trying to answer a very particular question; whether the microbiome profile of an individual is stable and stays with you throughout your life.

We hypothesize based on all the data we’ve collected that we have a unique strain based composition which is a fingerprint of our microbiota, but we haven’t proved this, and there are lots of factors that could alter this theory.

Part of this project is to try and identify whether our microbial fingerprint stable, and how stable it is. Once you leave a trace of your bacteria signature on a doorknob or television set, does it decay? And if so, how rapidly?

What do you think the future holds for using an individual’s unique microbiome in this way? Or for other applications?

The future is really exciting. We can potentially use the microbiome in forensic science, but that would be in the distant future. The human DNA program for forensic evidence took decades, and we’re only just starting our journey.

What’s most exciting is we can also use the microbiome information inside our bodies in personalized medicine, using the microbiome to predict whether an individual will respond to a particular therapy.

We could screen a cancer patient’s microbiome and determine if they have the biomarkers that can indicate their response to immunotherapy, which can help health care professionals identify their ideal strategy for therapy. We can use this to tailor treatment to the individual rather than the average treatment of a population.

How can Pittcon 2018 help you with your research?

What’s exciting about Pittcon is that it brings together a whole group of technological experts in areas that I wouldn’t normally have access to.

Being able to access the breadth of experience and technologies that are available to me here gives me more opportunities to expand my research objectives and to do something novel and exciting, that perhaps I wouldn’t normally have the chance to be involved in.

About Prof. Jack Gilbert

Professor Jack A Gilbert earned his Ph.D. from Unilever and Nottingham University, UK in 2002, and received his postdoctoral training at Queens University, Canada. He subsequently returned to the UK in 2005 to Plymouth Marine Laboratory at a senior scientist until his move to Argonne National Laboratory and the University of Chicago in 2010.

Currently, Professor Gilbert is the Director of the Microbiome Center and a Professor of Surgery at the University of Chicago. He is also Group Leader for Microbial Ecology at Argonne National Laboratory, Research Associate at the Field Museum of Natural History, Scientific Fellow at the Marine Biological Laboratory, and the Yeoh Ghim Seng Visiting Professorship in Surgery at the National University of Singapore.

Gilbert uses molecular analysis to test fundamental hypotheses in microbial ecology. He has authored more than 250 peer reviewed publications and book chapters on metagenomics and approaches to ecosystem ecology. He is the founding Editor in Chief of mSystems journal. In 2014 he was recognized on Crain’s Business Chicago’s 40 Under 40 List, and in 2015 he was listed as one of the 50 most influential scientists by Business Insider, and in the Brilliant Ten by Popular Scientist.

In 2016 he won the Altemeier Prize from the Surgical Infection Society, and the WH Pierce Prize from the Society for Applied Microbiology for research excellence. He also co-authored “Dirt is Good” published in 2017, a popular science guide to the microbiome and children’s health.

Tagged with:

About author

Related Articles